Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 556401Generated: October 30, 2026

N-Methylmorpholine N-oxide monohydrate → 7-(4-[1,2-Dihydroxyethyl]-phenyl)-4-ethoxy-9-methyl-2-piperazin-1-yl-thieno[2,3-d:4,5-d']dipyrimidine

https://huagongshe.com/reaction/556401

Reaction equation

Participants

RoleNameHCIDCharge
ReactantN-Methylmorpholine N-oxide monohydrateHCID 2724197—
Reactant4-Ethoxy-9-methyl-2-piperazin-1-yl-7-(4-vinylphenyl)-thieno[2,3-d:4,5-d']dipyrimidineHCID 59755085—
SolventAcetoneHCID 180—
Product7-(4-[1,2-Dihydroxyethyl]-phenyl)-4-ethoxy-9-methyl-2-piperazin-1-yl-thieno[2,3-d:4,5-d']dipyrimidineHCID 59755137—

Reaction Steps

0.20 g (0.46 mmol) 4-ethoxy-9-methyl-2-piperazin-1-yl-7-(4-vinylphenyl)-thieno[2,3-d:4,5-d′]dipyrimidine and 0.16 g (1.39 mmol) N-methylmorpholine-N-oxide-monohydrate were dissolved in 50 ml acetone. Then, 0.3 ml (4% aqueous) OSO4 solution was added and stirring was carried out at room temperature for 24 h. Thereafter, 100 ml 1 M NaCO3 solution were added and extraction with dichloromethane was carried out. Following flash chromatographic purification (chloroform/methanol, 8.5:1.5) 100 mg (46%) of the title compound is obtained. ESI-MS [m/z]: 466, melting point: >300° C.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08058285B2
Source datasetuspto-grants-2011_11
ORD IDord-17a06e2d9fef4257aad6dcacba70c420
Source noteuspto-grants-2011_11